The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK, and Novo Nordisk
AGD delivered ~86,000 whole genomes in 2023, including a unique diverse ancestry cohort
Expanded pharma engagement enhances AGD’s ability to develop multiomic datasets
Related news for (ILMN)
- Illumina advances personalized cancer care with new pharma development partnerships
- Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025
- Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
- Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company’s multiomics strategy
- Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis